Patient Leaflet Updated 07-Oct-2022 | Rosemont Pharmaceuticals Limited
Memantine Hydrochloride 10mg/ml Oral Solution
Memantine Hydrochloride 10mg/ml Oral Solution
1. What Memantine Oral Solution is and what it is used for
2. What you need to know before you take Memantine Oral Solution
3. How to take Memantine Oral Solution
4. Possible side effects
5. How to store Memantine Oral Solution
6. Contents of the pack and other information
Memantine Oral Solution belongs to a group of medicines known as anti-dementia medicines.
Memory loss in Alzheimer’s disease is due to a disturbance of message signals in the brain.
Memantine Oral Solution is used for the treatment of patients with moderate to severe Alzheimer’s disease.
Talk to your doctor before taking Memantine Oral Solution:
In these situations the treatment should be carefully supervised, and the clinical benefit of Memantine Oral Solution reassessed by your doctor on a regular basis.
You should inform your doctor if you have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet) or if you are suffering from states of renal tubulary acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction (poor kidney function)) or severe infections of the urinary tract (structure that carries urine), as your doctor may need to adjust the dose of your medicine.
If you suffer from renal impairment (kidney problems), your doctor should closely monitor your kidney function and if necessary adapt the memantine doses accordingly.
The use of medicinal products called amantadine (for the treatment of Parkinson’s disease), ketamine (a substance generally used as an anaesthetic), dextromethorphan (generally used to treat coughs) and other NMDA-antagonists at the same time should be avoided.
Memantine Oral Solution is not recommended for children and adolescents under the age of 18 years.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
In particular, memantine may change the effects of the following medicines and their dose may need to be adjusted by your doctor:
If you go into hospital, let your doctor know that you are taking Memantine Oral Solution.
Ask your doctor or pharmacist for advice before taking any medicine.
Tell your doctor if you are pregnant or planning to become pregnant. The use of memantine in pregnant women is not recommended.
Women taking Memantine Oral Solution should not breast-feed.
Your doctor will tell you whether your illness allows you to drive and to use machines safely. Also, Memantine Oral Solution may change your reactivity, making driving or operating machinery inappropriate.
This medicine contains sorbitol. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. Your doctor will advise you on what you should do.
Furthermore, this medicine contains potassium, less than 1mmol (39mg) per dose, i.e. essentially potassium free.
Always take Memantine Oral Solution exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Each millilitre (ml) of Memantine Oral Solution contains 10 milligrams (mg) memantine hydrochloride.
The recommended dose of Memantine Oral Solution for adults and elderly patients is 20mg (2ml) once a day.
In order to reduce the risk of side effects this dose is achieved gradually by the following daily treatment scheme:
Daily treatment scheme:
Week 1: Dose to take: 5mg (0.5ml)
Week 2: Dose to take: 10mg (1ml)
Week 3: Dose to take: 15mg (1.5ml)
Week 4 and beyond: Dose to take 20mg (2ml)
If you have impaired kidney function, your doctor will decide upon a dose that suits your condition. In this case, monitoring of your kidney function should be performed by your doctor at specified intervals.
Instructions for use
Continue to take Memantine Oral Solution as long as it is of benefit to you. Your doctor should assess your treatment on a regular basis.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Memantine Oral Solution can cause side effects, although not everybody gets them. If any of the following side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In general, the observed side effects are mild to moderate.
Common: affects 1 to 10 users in 100
Uncommon: affects 1 to 10 users in 1,000
Very rare: affects less than 1 user in 10,000
Not known: frequency cannot be estimated from the available data
Alzheimer’s disease has been associated with depression, suicidal ideation and suicide.
These events have been reported in patients treated with Memantine Oral Solution.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below).
By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
Memantine Oral Solution is presented as a clear and colourless, to light yellowish solution.
Memantine Oral Solution is available in bottles of 50ml or 100ml with an oral dosing syringe and bottle adaptor.
Not all pack sizes may be marketed.
This leaflet was last revised in 06/2022.
This medicinal product is authorised in the Member State of the EEA and United Kingdom under the following names:
Memantine Hydrochloride 10mg/ml Oral Solution: UK
Mémantine STRAGEN 10mg/ml, solution buvable: France
Other sources of information
This leaflet is also available in other formats for blind and partially-sighted patients. For large print and Braille, please go to
UK: www.xpil.medicines.org.uk
For an audio version, please go to www.rosemontpharma.com/products
Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
+44 (0)113 245 3567
+44 (0)800 919 312
+44 (0)795 762 3515
+44 (0)113 244 1400
http://www.rosemontpharma.com